Published on 6 Oct 2022 on Zacks via Yahoo Finance
Here's Why You Should Retain Chemed (CHE) Stock for Now
Chemed Corporation CHE is gaining from continued strength in the Roto-Rooter segment. The company’s earnings for the second quarter of 2022 beat the Zacks Consensus Estimate. The improvement in assisted living facility admissions buoys optimism. A favorable solvency position is encouraging too. However, the continued sales decline in the VITAS arm and pandemic-led disruptions do not bode well.
In the past year, this Zacks Rank #3 (Hold) stock has gained 4.3% against a 29.7% fall of the industry and a 14.2% drop of the S&P 500.
The renowned hospice care provider has a market capitalization of $6.66 billion. Its earnings surpassed estimates in the trailing four quarters, the average surprise being 6.3%.